The World: Washington - Bayer Healthcare forced by FDA to pull Yaz ad

Bayer Healthcare Pharmaceuticals has been forced to pull an ad for its birth control pill Yaz.

Concerns were expressed by the US Food and Drug Administration that the 60-second ad had gone too far in suggesting that the drug could help overcome PMS and acne.

The ad, by Young & Rubicam, was created to promote the fact that Yaz is approved as a treatment for premenstrual dysphoric disorder (PMDD).

However, the FDA said that the ad significantly failed to distinguish between PMDD and PMS, a problem that the drug isn't approved to treat.

Become a member of Campaign

Get the very latest news and insight from Campaign with unrestricted access to campaignlive.co.uk, plus get exclusive discounts to Campaign events.

Become a member

What is Campaign AI?

Our new premium service offering bespoke monitoring reports for your company.

Find out more

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content